ovarian cancer each year, nearly 400 more could be identified at an early, treatable stage when survival odds are better.
Smith is a resident in the Johns Hopkins department of gynecology and obstetrics in Baltimore.
The study was scheduled to be presented Sunday at the annual meeting of the American Society of Clinical Oncology (ASCO), in Chicago. Research presented at meetings is typically considered preliminary until published in a peer-reviewed journal.
“Detecting and treating ovarian cancer at an early stage saves lives and lowers health care costs compared to treatment of cancer at a more advanced, incurable stage,” Smith said in an ASCO news release.
“Having health insurance plays a major role in whether or not a woman has access to care providers who